Intended use: For the quantitative determination of Plasmin Inhibitor in human citrated plasma on IL Coagulation systems.
Principle: Based on synthetic chromogenic substrate and on plasmin inactivation.
Measurement principle
PI + Plasmin (in excess) 
PI • Plasmin + Plasmin (residual)
S-2403 + Plasmin (residual) Peptide + pNA
Vials and volumes:
- 2 x 2.5 mL Plasmin Reagent (lyo)
- 1 x 4 mL Chromogenic Substrate S-2403 (lyo)
- 2 x 9 mL Buffer (liq)
*ACL, ACL TOP, and HemosIL are trademarks of Instrumentation Laboratory.
Life Science Research
